Ron Erickson, Chairman and CEO of Know Labs, Inc KNW was recently a guest on Benzinga’s All-Access.
Know Labs is a medical technology company that develops non-invasive medical diagnostics. Its proprietary technology platform, Bio-RFID, uses electromagnetic energy in the form of radio waves to non-invasively capture molecular signatures which can be converted into physiologically meaningful information and insights.
While the technology platform can measure a range of different analytes both inside and outside the body, the company is focused on the non-invasive measurement of blood glucose. It reports that there are over 1.5 billion people around the world living with diabetes and pre-diabetes. Currently, there are no medical-grade commercially available, truly non-invasive means of measuring blood glucose levels.
Watch the full interview here:
Featured photo by National Cancer Institute on Unsplash.
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.